Panacea
PrivateLast Round
Series B
Extension
Jul 14, 2025
Est. Valuation
$105.26M
Total Funding Raised
$61.5M
Company Overview
Panacea is a healthcare technology company that provides AI-native FDA regulatory services by pairing expert consultants with an AI platform to accelerate the approval process for biotech and medtech companies.
Sector
FinTech
Verticals
Lending & Credit, Digital Banking
Business Model
B2C
Customer Profile
Payment Processing Fee, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacea Comps
Public and private peers based on sector, stage, and business model.
Panacea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 14, 2025 | ||||
| Series B | Jan 16, 2024 |
Panacea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valar Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2025
$37M round led by Valar Ventures.
- Jan 16, 2024
$25M round led by Valar Ventures
Panacea Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panacea's valuation, stock price, and market status.
